Skip to main content

Table 1 Demographic characteristics of the study participants across tertiles (T) of DII scores

From: Dietary inflammatory index in relation to the progression of hepatic steatosis and liver fibrosis: evaluation by elastography/Fibroscan

Variables

Tertiles of Dietary Inflammatory Index

P-value

T1

Low inflammatory

diet

T2

T3

High inflammatory

diet

Number

58

56

56

-

DII score

-1.55–1.35

1.40–2.40

2.40–3.68

-

Male, n%

24 (41.4%)

17 (30.4%)

21 (37.5%)

0.465†

Age, years

39.24 ± 13.06

40.82 ± 13.90

39.77 ± 12.10

0.806 ‡

Weight, kg

78.56 ± 15.34

85.17 ± 15.13

88.47 ± 16.29

0.003‡

BMI, kg/m²

27.73 ± 3.77

29.92 ± 4.7

30.95 ± 4.18

0.001‡

Physical activity, MET-h/week

9.43 ± 5.9

10.6 ± 5.2

9.85 ± 4.8

0.941‡

CVD, n%

12 (20.7%)

12 (21.4%)

5 (8.9%)

0.141†

Diabetes mellitus, n%

8 (13.8%)

10 (17.9%)

8 (14.3%)

0.807†

Current Smoker, n%

8 (13.8%)

13 (23.2%)

11 (19.6%)

0.429†

Hepatic steatosis, n%

Mild

27 (46.6%)

23 (41.1%)

11 (19.6%)

0.037†

Moderate

20 (34.5%)

19 (33.9%)

27 (48.2%)

Severe

11 (19%)

14 (25%)

18 (32.1%)

University education, n%

10 (17.2%)

6 (10.7%)

7 (12.5%)

0.843†

Anti-diabetic drugs use, n%

14 (24.1%)

13 (23.2%)

12 (21.4%)

0.941†

Dietary supplement use, n%

7 (12.3%)

8 (14.3%)

6 (10.7%)

0.848†

  1. Abbreviations BMI, body mass index; CVD, cardiovascular disease, MET-h, metabolic equivalent hours
  2. Notes Data are reported as mean and standard deviation or percentage (Frequency) as appropriate
  3. † P-values were calculated using the chi-squared test
  4. ‡ P-values were calculated using the one-way ANOVA test